Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 5697571, 9 pages
http://dx.doi.org/10.1155/2016/5697571
Clinical Study

Efficacy of Scutellaria baicalensis for the Treatment of Hand, Foot, and Mouth Disease Associated with Encephalitis in Patients Infected with EV71: A Multicenter, Retrospective Analysis

1Department of Pediatrics, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
2Department of Pediatrics, The First People’s Hospital of Yongkang, Jinhua, China
3Department of Pediatrics, The Affiliated Children’s Hospital of Zhejiang University Medical College, Hangzhou, China
4Department of Pediatrics, Hainan Provincial People’s Hospital, Haikou, China
5Department of Pediatrics, Zouping People’s Hospital, Binzhou, Shandong Province, China

Received 18 July 2016; Revised 3 September 2016; Accepted 20 September 2016

Academic Editor: Kota V. Ramana

Copyright © 2016 Hailong Lin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. L. Repass, W. C. Palmer, and F. F. Stancampiano, “Hand, foot, and mouth disease: Identifying and managing an acute viral syndrome,” Cleveland Clinic Journal of Medicine, vol. 81, no. 9, pp. 537–543, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. C. C. Y. Yip, S. K. P. Lau, P. C. Y. Woo, and K.-Y. Yuen, “Human enterovirus 71 epidemics: what's next?” Emerging Health Threats Journal, vol. 6, article 19780, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. Z.-C. Zhuang, Z.-Q. Kou, Y.-J. Bai et al., “Epidemiological research on hand, foot, and mouth disease in Mainland China,” Viruses, vol. 7, no. 12, pp. 6400–6411, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. C. W. Tan, J. K. F. Lai, I.-C. Sam, and Y. F. Chan, “Recent developments in antiviral agents against enterovirus 71 infection,” Journal of Biomedical Science, vol. 21, article 14, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. Q. Wang, W. Zhang, Y. Zhang et al., “Clinical features of severe cases of hand, foot and mouth disease with EV71 virus infection in China,” Archives of Medical Science, vol. 10, no. 3, pp. 510–516, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Chea, Y.-B. Cheng, K. Chokephaibulkit et al., “Workshop on use of intravenous immunoglobulin in hand, foot and mouth disease in Southeast Asia,” Emerging Infectious Diseases Journal, vol. 21, no. 1, 2015. View at Publisher · View at Google Scholar
  7. Y. He, J. Yang, G. Zeng et al., “Risk factors for critical disease and death from hand, foot and mouth disease,” Pediatric Infectious Disease Journal, vol. 33, no. 9, pp. 966–970, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Li, J. Zhang, and X. Zhang, “Modeling and preventive measures of hand, foot and mouth disease (HFMD) in China,” International Journal of Environmental Research and Public Health, vol. 11, no. 3, pp. 3108–3117, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. X.-Y. Huang, K. Kang, Y.-L. Xu et al., “Etiology surveillance of hand-foot-mouth disease in Henan province between 2008 and 2011,” Zhonghua Yu Fang Yi Xue Za Zhi, vol. 46, no. 10, pp. 883–887, 2012 (Swedish). View at Google Scholar · View at Scopus
  10. S. C. Yu, Y. T. Hao, J. Zhang et al., “Using interrupted time series design to analyze changes in hand, foot, and mouth disease incidence during the declining incidence periods of 2008–2010 in China,” Biomedical and Environmental Sciences, vol. 25, no. 6, pp. 645–652, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. J. Hsieh, M. H. Yen, Y. W. Chiang et al., “Gan-Lu-Siao-Du-yin, a prescription of traditional Chinese medicine, inhibited enterovirus 71 replication, translation, and virus-induced cell apoptosis,” Journal of Ethnopharmacology, vol. 185, pp. 132–139, 2016. View at Publisher · View at Google Scholar
  12. J. Liu, G. L. Zhang, G. Q. Huang et al., “Therapeutic effect of Jinzhen oral liquid for hand foot and mouth disease: a randomized, multi-center, double-blind, placebo-controlled trial,” PLoS ONE, vol. 9, no. 4, Article ID e94466, 2014. View at Publisher · View at Google Scholar
  13. X. Wu, H. Zhang, J. M. Salmani, R. Fu, and B. Chen, “Advances of wogonin, an extract from Scutellaria baicalensis, for the treatment of multiple tumors,” OncoTargets and Therapy, vol. 9, pp. 2935–2943, 2016. View at Publisher · View at Google Scholar
  14. K. Zandi, T. Lim, N. Rahim et al., “Extract of Scutellaria baicalensis inhibits dengue virus replication,” BMC Complementary and Alternative Medicine, vol. 13, article 91, 2013. View at Publisher · View at Google Scholar
  15. M.-J. Hour, S.-H. Huang, C.-Y. Chang et al., “Baicalein, ethyl acetate, and chloroform extracts of Scutellaria baicalensis inhibit the neuraminidase activity of pandemic 2009 H1N1 and seasonal influenza A viruses,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 750803, 11 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Kallifatidis, V. Rausch, B. Baumann et al., “Sulforaphane targets pancreatic tumour-initiating cells by NF-κB-induced antiapoptotic signalling,” Gut, vol. 58, no. 7, pp. 949–963, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Yang, X. L. Zheng, H. Sun et al., “Catalase suppression-mediated H2O2 accumulation in cancer cells by wogonin effectively blocks tumor necrosis factor-induced NF-κB activation and sensitizes apoptosis,” Cancer Science, vol. 102, no. 4, pp. 870–876, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. D.-H. Lee, J. G. Rhee, and Y. J. Lee, “Reactive oxygen species up-regulate p53 and puma; a possible mechanism for apoptosis during combined treatment with TRAIL and wogonin,” British Journal of Pharmacology, vol. 157, no. 7, pp. 1189–1202, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. S. A. Rushworth and O. Micheau, “Molecular crosstalk between trail and natural antioxidants in the treatment of cancer,” British Journal of Pharmacology, vol. 157, no. 7, pp. 1186–1188, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. Q. Zhu, Y. Hao, J. Ma, S. Yu, and Y. Wang, “Surveillance of hand, foot, and mouth disease in Mainland China (2008-2009),” Biomedical and Environmental Sciences, vol. 24, no. 4, pp. 349–356, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Nassef, C. Ziemer, and D. S. Morrell, “Hand-foot-and-mouth disease: a new look at a classic viral rash,” Current Opinion in Pediatrics, vol. 27, no. 4, pp. 486–491, 2015. View at Publisher · View at Google Scholar
  22. S. M. Wang, “Milrinone in enterovirus 71 brain stem encephalitis,” Frontiers in Pharmacology, vol. 7, article 82, 2016. View at Publisher · View at Google Scholar
  23. P. Linsuwanon, J. Puenpa, S.-W. Huang et al., “Epidemiology and seroepidemiology of human enterovirus 71 among Thai populations,” Journal of Biomedical Science, vol. 21, no. 1, article 16, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. W. Li, G. Teng, H. Tong et al., “Study on risk factors for severe hand, foot and mouth disease in China,” PLoS ONE, vol. 9, no. 1, Article ID e87603, 2014. View at Publisher · View at Google Scholar
  25. Y. Fang, S. Wang, L. Zhang et al., “Risk factors of severe hand, foot and mouth disease: a meta-analysis,” Scandinavian Journal of Infectious Diseases, vol. 46, no. 7, pp. 515–522, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Zeng, F. Wen, Y. Gan, and W. Huang, “MRI and associated clinical characteristics of EV71-induced brainstem encephalitis in children with hand-foot-mouth disease,” Neuroradiology, vol. 54, no. 6, pp. 623–630, 2012. View at Publisher · View at Google Scholar · View at Scopus